Product Information
SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1174 per ML under NDC 00378920535. Its NADAC has been published 190 times since Nov 9, 2022.
Strength
1 g/10mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378920535
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212913On Market Since
9/22/2022
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 190 times since Nov 9, 2022, and over the history we have for it it has declined 63.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1174 per ML |
|---|---|
| All-time high | $0.3838 (Oct 11, 2023) |
| All-time low | $0.1174 (Jun 17, 2026) |
| 52-week high | $0.1316 |
| 52-week low | $0.1174 |
| Median price | $0.2426 |
| Average price | $0.2379 |
| Largest weekly change | +53.6% (Jun 19, 2024) |
| Weeks tracked | 190 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the sucralfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Mylan Pharmaceuticals Inc., is $0.1174 per ML (NDC 00378920535), effective Jun 24, 2026.
How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 63.5%. It has been tracked across 190 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?
Since Nov 9, 2022, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1174 (Jun 17, 2026) to a high of $0.3838 (Oct 11, 2023), with a median of $0.2426 per ML.
Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SUCRALFATE 1 GM/10 ML SUSP, so no direct lower-cost alternative is listed.
Who manufactures SUCRALFATE 1 GM/10 ML SUSP?
SUCRALFATE 1 GM/10 ML SUSP (NDC 00378920535) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification